Goldenwell Biotech (GWLL) Other Gross PP&E Adjustments (2021 - 2024)
Goldenwell Biotech filings provide 4 years of Other Gross PP&E Adjustments readings, the most recent being -$21565.0 for Q1 2024.
- On a quarterly basis, Other Gross PP&E Adjustments changed N/A to -$21565.0 in Q1 2024 year-over-year; TTM through Mar 2024 was -$21565.0, a N/A change, with the full-year FY2023 number at -$23665.0, up 10.18% from a year prior.
- Other Gross PP&E Adjustments hit -$21565.0 in Q1 2024 for Goldenwell Biotech, up from -$23665.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$21565.0 in Q1 2024 to a low of -$63561.0 in Q1 2021.
- Median Other Gross PP&E Adjustments over the past 4 years was -$38558.5 (2022), compared with a mean of -$40254.0.
- Biggest five-year swings in Other Gross PP&E Adjustments: soared 45.96% in 2022 and later grew 10.18% in 2023.
- Goldenwell Biotech's Other Gross PP&E Adjustments stood at -$48752.0 in 2021, then surged by 45.96% to -$26346.0 in 2022, then increased by 10.18% to -$23665.0 in 2023, then grew by 8.87% to -$21565.0 in 2024.
- The last three reported values for Other Gross PP&E Adjustments were -$21565.0 (Q1 2024), -$23665.0 (Q4 2023), and -$26346.0 (Q4 2022) per Business Quant data.